The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

This Week in the Twitterverse: Weekend Reading

Here’s your dose of weekly biotech news, all wrapped up in one weekend-friendly package thanks to our Twitter stream:

  • RT @ArsenicMicrobes: We come in peace — Funny! But agree with @matthewherper on this one: not an alien
  • Never too early for biotechs and VCs to understand and plan for payer-focused endpoints via @InVivoBlogChris
  • My short presentation from the CHLA holiday event on Canadian Biotech and Pharma Licensing Trends
  • Canadian Biotech and Healthcare Licensing Trends in 2010
  • Ogilvy Renault ‘s Rick Sutin and BIOTECanada’s Peter Brenders on bringing flow-thru shares to the biotech sector in Canada
  • What’s your best price? Amgen’s Nplate latest example of drug winning NICE backing after offering rebate to UK’s NHS, from @reutersBenHir:
  • BC biotech company bets the farm on GM non-browning apples
  • Made here, bought elsewhere… RT @robannan: Innovation moves south – government watches it go. New blog post.
  • Merck Prez Ken Frazier to become CEO in Jan. Background from Fierce Biotech at
  • One of the outcomes from H1N1/swine flu pandemic… RT @CBCHealth: Ont. to give new powers to chief medical officer
  • RT @jonmrich: Forget Harry Potter. Call of Duty: Black Ops: Sold $650 million in 5 days. Breaks EVERY entertainment opening. Amazing.
  • Allon (TSX:NPC) lands $625k grant from MJFF for pre-clinical work on davunetide as a treatment for Parkinson’s
  • NB Premier says he’s open to idea of regional fund, proposes $50m for Atlantic biotech/cleantech/IT
  • Medical genetics and personalized medicine issue of Stanford Med

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 128 other followers